1) human amino-terminal pro-brain natriuretic peptide
人氨基末端脑钠肽
1.
Objective To clone human amino-terminal pro-brain natriuretic peptide gene and obtain purified NT-proBNP for future proparation of antibody.
目的:克隆人氨基末端脑钠肽(am ino-term inal pro-brain natriuretic peptide,NT-proBNP)基因,构建原核表达载体并纯化表达产物。
2) NT-BNP
氨基末端脑钠肽
1.
Objective: To compare the effects of insulin plus rosiglitazone with insulin plus metformin on serum N-terminal pro-brain natriuretic peptide(NT-BNP), adiponectin, leptin and C reaction protein(CRP) in type 2 diabetes mellitus.
目的：比较胰岛素和罗格列酮联合治疗与胰岛素和二甲双胍联合治疗两种方案对2型糖尿病患者血清氨基末端脑钠肽(NT-BNP)、脂联素、瘦素及C反应蛋白(CRP)水平的影响。
3) N-terminal pro-brain natriuretic peptide
氨基末端脑钠肽前体
1.
Objective:To explore the plasma N-terminal pro-brain natriuretic peptide(NT-proBNP) level of neonates with neonatal asphyxia and its clinical significance.
目的:探讨窒息新生儿血浆氨基末端脑钠肽前体(NT-proBNP)水平及临床意义。
2.
Serum N-terminal pro-brain natriuretic peptide levels on the prognosis of multiple organ dysfunction syndrome in the elderly;
目的探讨老年多器官功能不全综合征(MODSE)患者血清氨基末端脑钠肽前体(NT-proBNP)水平变化及其临床意义。
4) NT-proBNP
氨基末端-脑钠肽前体
1.
Diagnostic value of NT-proBNP in the differentiation of acute dyspnea;
急诊呼吸困难患者氨基末端-脑钠肽前体的鉴别诊断价值
5) NT-proBNP
氨基末端脑钠肽前体
1.
To study the relationship between N-temrina probarin natriuretic peptide(NT-proBNP) level and cardiac functions in patients with congestive heart failure(CHF),the plasma level of NT-proBNP in 108 patients with CHF and 30 healthy controls were measured by electrochemiluminescence immunoassay(ECLIA) and left ventricular ejection fraction(LVEF) was measured by echocardiography.
探讨充血性心力衰竭(CHF)患者血浆氨基末端脑钠肽前体(NT-proBNP)水平与心功能的关系。
2.
Diastolic dysfunction is one of the important triggers for the release of brain natriuretic petide(BNP) and N-terminal pro-natriuretic petide(NT-proBNP) from the ventricular myocardium.
舒张功能不全是触发心肌细胞释放脑钠肽(BNP)和氨基末端脑钠肽前体(NT-proBNP)的重要因素。
3.
Methods HFEI in 116 patients with CHF(CHF group) and 24 normal controls(control group) were evaluated and compared with the levels of contemporaneous NT-ProBNP and the NYHA class, and the sensitivity and specificity of HFEI for CHF diagnosis were appraised.
方法:前瞻性研究慢性心力衰竭患者116例(心衰组),正常者24例(对照组),所有入选者进行心衰超声指数的评分,并将该评分与同期血浆氨基末端脑钠肽前体(NT-ProBNP)水平及纽约心功能分级(NYHA)进行比较,同时评价其诊断慢性心力衰竭的敏感性与特异性。
6) NT-probrain natriuretic peptide
氨基酸末端脑钠肽前体
补充资料：心房肽素,人心房利钠多肽
药物名称：心房肽
英文名：
别名： 心房肽素,人心房利钠多肽;心钠素 ,心房肽
适应症：
用于治疗高血压、肾性或肝性腹水、心力衰竭和原发性醛固酮增多症等，疗效显著。
用量用法： 静滴：每次０．２～０．４ｍｇ。
规格： 粉针剂：０．２ｍｇ。
类别：降血压药
英文名：
别名： 心房肽素,人心房利钠多肽;心钠素 ,心房肽
适应症：
用于治疗高血压、肾性或肝性腹水、心力衰竭和原发性醛固酮增多症等，疗效显著。
用量用法： 静滴：每次０．２～０．４ｍｇ。
规格： 粉针剂：０．２ｍｇ。
类别：降血压药
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条